| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
OKUR
OnKure Therapeutics
|
Jun 24, 2026 | BUY |
Buy
+442.7% avg upside
13 analysts
|
$30.00
566.59% Upside
|
· |
|
ARGX
Argenx Se
|
Jun 24, 2026 | BUY |
Strong Buy
-15.8% avg upside
46 analysts
|
$1014.00
14.31% Upside
|
+4.2% |
|
ENGN
enGene Holdings
|
Jun 22, 2026 | HOLD |
Buy
+471.5% avg upside
13 analysts
|
— | · |
|
FULC
Fulcrum Therapeutics
|
Jun 22, 2026 | HOLD |
Hold
+132.0% avg upside
14 analysts
|
— | · |
|
CAPR
Capricor Therapeutics
|
Jun 18, 2026 | BUY |
Strong Buy
+88.0% avg upside
12 analysts
|
$54.00
104.14% Upside
|
+7.1% |
|
ASND
Ascendis Pharma
|
Jun 15, 2026 | BUY |
Strong Buy
+3.6% avg upside
24 analysts
|
$262.00
0.42% Upside
|
+3.5% |
|
SABS
SAB Biotherapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
+178.5% avg upside
14 analysts
|
$14.00
268.46% Upside
|
· |
|
SPRB
Spruce Biosciences
|
May 27, 2026 | BUY |
Strong Buy
+82.6% avg upside
14 analysts
|
$230.00
317.29% Upside
|
-0.4% |
|
TARA
Protara Therapeutics
|
May 20, 2026 | BUY |
Strong Buy
+1115.6% avg upside
21 analysts
|
$28.00
579.66% Upside
|
-18.1% |
|
URGN
Urogen Pharma
|
May 19, 2026 | BUY |
Strong Buy
+9.9% avg upside
16 analysts
|
$40.00
15.88% Upside
|
+16.1% |
|
CALC
CalciMedica
|
May 15, 2026 | BUY |
Buy
+3403.1% avg upside
9 analysts
|
$10.00
1125.68% Upside
|
+30.3% |
|
CLYM
Climb Bio
|
May 15, 2026 | BUY |
Strong Buy
+40.4% avg upside
18 analysts
|
$18.00
37.53% Upside
|
+0.0% |
|
EQ
Equillium
|
May 15, 2026 | BUY |
Strong Buy
+185.9% avg upside
14 analysts
|
$7.00
129.44% Upside
|
+27.1% |
|
CRNX
Crinetics Pharmaceuticals
|
May 11, 2026 | BUY |
Strong Buy
+116.4% avg upside
20 analysts
|
$84.00
128.84% Upside
|
-8.9% |
|
TRVI
Trevi Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+11.5% avg upside
16 analysts
|
$24.00
32.19% Upside
|
-2.1% |
|
CPRX
Catalyst Pharma
|
May 07, 2026 | HOLD |
Strong Buy
-17.3% avg upside
15 analysts
|
— | +0.7% |
|
OCGN
Ocugen
|
May 06, 2026 | BUY |
Strong Buy
+519.8% avg upside
17 analysts
|
$10.00
566.64% Upside
|
-10.7% |
|
VRDN
Viridian Therapeutics
|
Apr 13, 2026 | HOLD |
Strong Buy
+90.3% avg upside
32 analysts
|
— | +8.8% |
|
LXEO
Lexeo Therapeutics, Inc.
|
Mar 31, 2026 | BUY |
Strong Buy
+306.4% avg upside
11 analysts
|
$20.00
321.11% Upside
|
-11.3% |
|
AARD
Aardvark Therapeutics, Inc.
|
Feb 27, 2026 | BUY |
Buy
+298.2% avg upside
12 analysts
|
$21.00
338.45% Upside
|
-61.8% |
|
LGND
Ligand Pharma
|
Feb 27, 2026 | BUY |
Strong Buy
-25.0% avg upside
15 analysts
|
$277.00
8.81% Downside
|
+49.2% |
|
VERU
Veru
|
Feb 12, 2026 | BUY |
Strong Buy
+559.9% avg upside
10 analysts
|
$25.00
730.56% Upside
|
+5.8% |
|
CUE
Cue Biopharma
|
Feb 10, 2026 | HOLD |
Strong Buy
-62.9% avg upside
9 analysts
|
— | +127.6% |
|
IMVT
Immunovant
|
Feb 09, 2026 | BUY |
Strong Buy
-0.5% avg upside
24 analysts
|
$54.00
38.92% Upside
|
+38.0% |
|
QNCX
Quince Therapeutics
|
Nov 14, 2025 | BUY |
Hold
+2250.5% avg upside
15 analysts
|
$100.00
10498.82% Upside
|
-93.6% |
|
XERS
Xeris Pharmaceuticals
|
Nov 07, 2025 | BUY |
Strong Buy
+21.2% avg upside
10 analysts
|
$18.00
134.04% Upside
|
-7.1% |
|
RYTM
Rhythm Pharmaceuticals
|
Nov 04, 2025 | HOLD |
Strong Buy
+10.4% avg upside
19 analysts
|
— | -8.7% |
|
BMRN
BioMarin Pharmaceutical
|
Oct 28, 2025 | BUY |
Strong Buy
+60.3% avg upside
52 analysts
|
$98.00
66.02% Upside
|
+4.5% |
|
CGEN
Compugen
|
Oct 14, 2025 | BUY |
Strong Buy
+153.9% avg upside
8 analysts
|
$4.00
91.41% Upside
|
+43.6% |
|
AVTX
Avalo Therapeutics
|
Sep 29, 2025 | BUY |
Strong Buy
+197.5% avg upside
19 analysts
|
$35.00
92.33% Upside
|
+25.6% |
|
TECX
Tectonic Therapeutic
|
Sep 03, 2025 | BUY |
Strong Buy
+77.4% avg upside
24 analysts
|
$80.00
150.09% Upside
|
+70.8% |
|
ALNY
Alnylam Pharma
|
Aug 04, 2025 | BUY |
Strong Buy
+17.6% avg upside
51 analysts
|
$490.00
68.08% Upside
|
-31.7% |
|
NCNA
Nucana
|
Sep 16, 2024 | BUY |
Buy
+715.8% avg upside
9 analysts
|
$25.00
1512.89% Upside
|
-99.7% |
|
TEVA
Teva Pharmaceutical
|
May 20, 2024 | HOLD |
Buy
-11.6% avg upside
39 analysts
|
— | -0.2% |
|
CYTK
Cytokinetics
|
May 14, 2024 | BUY |
Strong Buy
+5.2% avg upside
36 analysts
|
$106.00
28.95% Upside
|
-49.5% |
|
PDSB
PDS Biotechnology
|
Mar 28, 2024 | BUY |
Strong Buy
+1612.3% avg upside
11 analysts
|
— | -68.2% |
|
XFOR
X4 Pharmaceuticals
|
Dec 18, 2023 | BUY |
Strong Buy
+520.0% avg upside
15 analysts
|
— | -8.0% |
|
MIST
Milestone Pharmaceuticals
|
Nov 13, 2023 | BUY |
Strong Buy
+567.1% avg upside
7 analysts
|
$11.00
787.16% Upside
|
-21.4% |
|
GRCE
Grace Therapeutics
|
Jul 10, 2023 | BUY |
Strong Buy
+153.0% avg upside
9 analysts
|
— | +8.9% |
|
CLNN
Clene
|
Oct 04, 2022 | HOLD |
Strong Buy
+447.6% avg upside
11 analysts
|
— | -71.8% |
|
CASIF
CASI Pharmaceuticals
|
May 26, 2022 | BUY |
Strong Buy
+19387.2% avg upside
5 analysts
|
$60.00
46053.86% Upside
|
· |
|
BXRXQ
Baudax Bio
|
Mar 21, 2022 | BUY |
Strong Buy
+18749999900.0% avg upside
3 analysts
|
$200.00
19999999899.97% Upside
|
· |
|
CRBP
Corbus Pharmaceuticals
|
Nov 16, 2021 | HOLD |
Strong Buy
+309.9% avg upside
20 analysts
|
— | -87.9% |
|
WINT
Windtree Therapeutics
|
Jun 04, 2021 | BUY |
Strong Buy
+48952.7% avg upside
6 analysts
|
$8.00
57042.77% Upside
|
· |
|
ATXI
Avenue Therapeutics
|
Jun 02, 2021 | BUY |
Strong Buy
+6328.6% avg upside
4 analysts
|
$12.00
4185.78% Upside
|
· |
|
VCNX
Vaccinex
|
May 18, 2021 | BUY |
Buy
+808.9% avg upside
2 analysts
|
$7.00
808.89% Upside
|
· |
|
CMMB
Chemomab Therapeutics
|
May 07, 2021 | BUY |
Strong Buy
+1611.8% avg upside
6 analysts
|
$42.00
2541.45% Upside
|
-84.7% |
|
TRVN
Trevena
|
May 06, 2021 | HOLD |
Buy
+949900.0% avg upside
11 analysts
|
— | · |
|
AMRN
Amarin
|
Dec 31, 2020 | HOLD |
Hold
-47.1% avg upside
18 analysts
|
— | -31.1% |
|
ADMA
ADMA Biologics
|
Dec 31, 2020 | HOLD |
Strong Buy
+49.4% avg upside
15 analysts
|
— | -27.7% |
|
OTLK
Outlook Therapeutics
|
Dec 31, 2020 | HOLD |
Buy
+470.6% avg upside
11 analysts
|
— | +4.6% |
|
EVFM
Evofem Biosciences
|
Sep 11, 2020 | HOLD |
Buy
+278863.4% avg upside
8 analysts
|
— | · |
|
LITS
Lite Strategy
|
May 10, 2019 | BUY |
Buy
+1139.3% avg upside
13 analysts
|
$7.00
679.43% Upside
|
· |
|
TLPH
Talphera
|
May 09, 2019 | HOLD |
Buy
+354.6% avg upside
15 analysts
|
— | -51.3% |
|
GRDX
GridAI Technologies
|
Apr 03, 2019 | BUY |
Strong Buy
+359.6% avg upside
7 analysts
|
$8.00
81.50% Upside
|
-78.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.